Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 232% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 7/9 — financially strong with improving fundamentals
- ROE of 0.7% — below-average profitability
- Revenue growing at 8% annually
ENVISTA HOLDINGS CORPORATION (NVST) is a Healthcare company operating in Dental Equipment & Supplies, listed on the NYSE , with a market capitalisation of $4.1 billion . Key value metrics: P/E ratio 185.6, P/B ratio 1.33, Piotroski F-Score 7 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
ENVISTA HOLDINGS CORPORATION — Fundamental Analysis Summary
ENVISTA HOLDINGS CORPORATION (NVST) is currently trading 232% above its Graham Number of $7.62, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 185.6x.
On financial health, NVST shows a strong Piotroski F-Score of 7/9, indicating improving fundamentals across profitability, leverage, and efficiency, and modest return on equity of 0.7% (sector average: -19.8%), and manageable leverage with a debt-to-equity ratio of 0.47.
StockPik's composite Value Score for NVST is 77/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
NVST reports a solid gross margin of 54.2% (sector average: 33.5%) and a modest operating margin of 6.4%.
NVST shows revenue growing at 8% year-over-year, with earnings growing at 104%.